News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
156,847 Results
Type
Article (6223)
Company Profile (103)
Press Release (150521)
Section
Business (49772)
Career Advice (233)
Deals (7403)
Drug Delivery (22)
Drug Development (20661)
Employer Resources (22)
FDA (2072)
Job Trends (4951)
News (80053)
Policy (4865)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (5)
2026 Biotech Bay Standard (1)
Academia (484)
Adcomms (3)
Allergies (16)
Alliances (13312)
ALS (29)
Alzheimer's disease (368)
Antibody-drug conjugate (ADC) (29)
Approvals (2082)
Artificial intelligence (63)
Autoimmune disease (8)
Automation (3)
Bankruptcy (61)
Best Places to Work (4286)
BIOSECURE Act (13)
Biosimilars (9)
Biotechnology (96)
Bladder cancer (23)
Brain cancer (7)
Breast cancer (113)
Cancer (680)
Cardiovascular disease (24)
Career advice (216)
Career pathing (4)
CAR-T (56)
Cell therapy (175)
Cervical cancer (6)
Clinical research (16749)
Collaboration (271)
Compensation (100)
Complete response letters (3)
COVID-19 (533)
CRISPR (7)
C-suite (102)
Cystic fibrosis (27)
Data (669)
Depression (7)
Diabetes (68)
Diagnostics (1152)
Digital health (2)
Diversity, equity & inclusion (8)
Drug discovery (47)
Drug pricing (16)
Drug shortages (5)
Duchenne muscular dystrophy (23)
Earnings (15111)
Editorial (4)
Employer branding (1)
Employer resources (21)
Events (29144)
Executive appointments (270)
FDA (2321)
Featured Employer (14)
Frontotemporal dementia (5)
Funding (232)
Gene editing (20)
Generative AI (4)
Gene therapy (91)
GLP-1 (132)
Government (497)
Guidances (10)
Healthcare (2773)
Huntington's disease (6)
IgA nephropathy (6)
Immunology and inflammation (23)
Indications (10)
Infectious disease (565)
Inflammatory bowel disease (52)
Inflation Reduction Act (2)
Influenza (18)
Intellectual property (35)
Interviews (18)
IPO (3449)
IRA (11)
Job creations (804)
Job search strategy (202)
Kidney cancer (1)
Labor market (7)
Layoffs (57)
Legal (1182)
Liver cancer (15)
Lung cancer (62)
Lymphoma (51)
Management (4)
Manufacturing (85)
MASH (9)
Medical device (1300)
Medtech (1300)
Mergers & acquisitions (4144)
Metabolic disorders (142)
Multiple sclerosis (27)
NASH (1)
Neurodegenerative disease (16)
Neuropsychiatric disorders (3)
Neuroscience (496)
NextGen: Class of 2025 (1215)
Non-profit (650)
Northern California (827)
Now hiring (6)
Obesity (70)
Opinion (40)
Ovarian cancer (32)
Pain (23)
Pancreatic cancer (22)
Parkinson's disease (36)
Partnered (5)
Patents (55)
Patient recruitment (29)
Peanut (12)
People (19003)
Pharmaceutical (12)
Phase I (6478)
Phase II (7902)
Phase III (4249)
Pipeline (326)
Podcasts (3)
Policy (32)
Postmarket research (322)
Preclinical (2738)
Press Release (51)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (57)
Rare diseases (72)
Real estate (1736)
Recruiting (13)
Regulatory (3542)
Reports (14)
Research institute (502)
Resumes & cover letters (24)
Rett syndrome (3)
RSV (5)
Schizophrenia (13)
Series A (39)
Series B (30)
Service/supplier (3)
Sickle cell disease (12)
Southern California (772)
Special edition (1)
Spinal muscular atrophy (37)
Sponsored (5)
Startups (1103)
State (1)
Stomach cancer (2)
Supply chain (15)
Tariffs (3)
The Weekly (3)
United States (6812)
Vaccines (98)
Venture capitalists (8)
Webinars (6)
Weight loss (31)
Women's health (5)
Worklife (2)
Date
Today (39)
Last 7 days (221)
Last 30 days (855)
Last 365 days (10179)
2025 (2492)
2024 (10503)
2023 (11385)
2022 (13869)
2021 (14800)
2020 (12252)
2019 (9429)
2018 (7249)
2017 (7378)
2016 (6856)
2015 (7913)
2014 (6051)
2013 (4865)
2012 (5386)
2011 (5909)
2010 (5394)
Location
Africa (156)
Alabama (27)
Alaska (1)
Arizona (33)
Arkansas (4)
Asia (9053)
Australia (2099)
California (1910)
Canada (579)
China (106)
Colorado (38)
Connecticut (72)
Delaware (25)
Europe (19825)
Florida (189)
Georgia (30)
Idaho (13)
Illinois (149)
India (3)
Indiana (97)
Iowa (2)
Japan (33)
Kansas (11)
Kentucky (3)
Louisiana (1)
Maine (5)
Maryland (218)
Massachusetts (1373)
Michigan (71)
Minnesota (97)
Missouri (9)
Montana (8)
Nebraska (3)
Nevada (5)
New Hampshire (5)
New Jersey (440)
New Mexico (8)
New York (484)
North Carolina (319)
North Dakota (3)
Northern California (827)
Ohio (41)
Oklahoma (6)
Oregon (5)
Pennsylvania (375)
Puerto Rico (3)
Rhode Island (6)
South America (220)
South Carolina (2)
Southern California (772)
Tennessee (17)
Texas (669)
Utah (25)
Virginia (16)
Washington D.C. (8)
Washington State (309)
Wisconsin (9)
156,847 Results for "fujifilm diosynth biotechnologies texas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Jacobs Selected to Support Delivery of $1.2B Expansion of FUJIFILM Diosynth Biotechnologies’ Large-Scale Biologics Manufacturing Site
Jacobs was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina.
June 27, 2024
·
4 min read
Deals
FUJIFILM Diosynth Biotechnologies: There’s a New Cell Therapy Employer in Thousand Oaks
FUJIFILM Diosynth Biotechnologies is offering unique opportunities to join one of the top global CDMOs focused on solving some of the most complex healthcare challenges.
December 2, 2022
·
5 min read
·
Heather McKenzie
Bio NC
FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases
FUJIFILM Diosynth Biotechnologies announced an agreement with argenx to manufacture efgartigimod, a monoclonal antibody fragment to target the neonatal Fc receptor, in patients with severe autoimmune disease.
October 27, 2022
·
3 min read
Press Releases
FUJIFILM Irvine Scientific Sells its Medical Media Business to Astorg
January 21, 2025
·
2 min read
Business
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
Chimeron Bio, today announced it has entered into a manufacturing agreement with FUJIFILM Diosynth Biotechnologies (FDB), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies, to advance the Company’s Oncology portfolio to the clinic.
April 12, 2022
·
3 min read
Business
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies Announce Collaboration to Support Development and Manufacturing of Gene Therapies for Genetic Diseases
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies today announced a strategic collaboration to support the development and manufacturing of LEXEO’s AAV-mediated gene therapies.
October 13, 2021
·
4 min read
Business
aTyr Pharma and FUJIFILM Diosynth Biotechnologies Announce Manufacturing Agreement for aTyr’s Lead Therapeutic Candidate ATYR1923
aTyr Pharma, Inc. (Nasdaq: LIFE), and FUJIFILM Diosynth Biotechnologies, today announced a manufacturing agreement for ATYR1923, aTyr Pharma’s lead therapeutic candidate that is currently in clinical development for pulmonary sarcoidosis, a major form of interstitial lung disease (ILD).
November 30, 2021
·
6 min read
Press Releases
FUJIFILM Irvine Scientific Adds Key Products to Its Life Sciences Portfolio from FUJIFILM Wako Chemicals U.S.A.
September 27, 2024
·
2 min read
Job Trends
FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today that its College Station, Texas, site will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed,
July 27, 2020
·
3 min read
BioMidwest
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
VolitionRx Limited has agreed a supply agreement with Fujifilm Vet Systems Co. Ltd, a leading veterinary diagnostic laboratory service, to launch the Nu.Q® Vet Cancer Test to veterinarians in Japan.
March 20, 2024
·
6 min read
1 of 15,685
Next